Seroprevalence of parvovirus B19 antibody in HIV-positive asymptomatic persons

David H. Dockrell, Gregory A. Poland, Thomas F. Smith, Mary F. Jones, Peter C. Wollan, Scott R. Strickland, Claire Pomeroy

Research output: Contribution to journalArticle

1 Scopus citations


Objective: Parvovirus B19 is an important cause of chronic anemia in human immunodeficiency virus (HIV)-positive patients. Extensive seroprevalence studies for parvovirus B19 in HIV-positive individuals have not been carried out in the United States. The authors compared the seroprevalence for parvovirus B19 among patients with asymptomatic HIV infection and healthy blood donors. Methods: The seroprevalence of IgG antibodies to VP-1, a parvovirus B19 structural protein, was determined using an indirect enzyme immunoassay (EIA) and a Western blot assay in 72 HIV- positive adults without prior opportunistic infection or acquired immunodeficiency syndrome (AIDS)-related malignancy and results were compared to those of 134 healthy blood donors. Results: There was a significantly higher seroprevalence for parvovirus B19 in HIV-positive subjects (57/72, 79%) than in the controls (58/134, 43%) (P < 0.001). Analysis by indirect EIA of the HIV-positive subjects 1 year later showed no significant change in seropositivity (48/70, 69%). For HIV-positive subjects, B19 seropositivity was not significantly related to age, sex, or CD4 count, but the parvovirus index did correlate with the total IgG level at both time points (P = 0.014 at the first estimation and P = 0.045 1 year later). Western blot analysis of IgG antibody to the VP-1 protein showed that 49 of 71 (69%) of the HIV- positive subjects were positive at the beginning of the study, and 50 of 71 (70%) were positive 1 year later. Conclusions: These results suggest an increased seropositivity to parvovirus B19 among HIV-positive individuals compared to healthy controls.

Original languageEnglish (US)
Pages (from-to)99-104
Number of pages6
JournalInternational Journal of Infectious Diseases
Issue number2
StatePublished - 1997
Externally publishedYes


  • Asymptomatic HIV-positive
  • B19 antibody
  • Parvovirus seroprevalence

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Seroprevalence of parvovirus B19 antibody in HIV-positive asymptomatic persons'. Together they form a unique fingerprint.

  • Cite this

    Dockrell, D. H., Poland, G. A., Smith, T. F., Jones, M. F., Wollan, P. C., Strickland, S. R., & Pomeroy, C. (1997). Seroprevalence of parvovirus B19 antibody in HIV-positive asymptomatic persons. International Journal of Infectious Diseases, 2(2), 99-104.